Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | ABCC9 | O60706 | 2/20 | 0.34 |
| ▸ | ABCC8 | Q09428 | 2/20 | 0.34 |
| ▸ | KCNJ11 | Q14654 | 2/20 | 0.34 |
| ▸ | KCNJ8 | Q15842 | 2/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29727517 | 1.00 | LMNA (0.52) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL316983 | 0.84 | HTT (0.44) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL31088294 | 0.84 | HTT (0.44) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL4635144 | 0.82 | LMNA (0.43) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL308766 | 0.80 | HTT (0.38) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL9716203 | 0.80 | LMNA (0.41) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL31509682 | 0.78 | LMNA (0.40) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL8755109 | 0.78 | LMNA (0.40) | LMNAHTTKMT2AMEN1KDM4E | |
| SCHEMBL8137353 | 0.77 | — | — | |
| SCHEMBL31547630 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113559939-B | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2023-06-23 | — | — | CN | claimed |
| CN-113713858-B | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2023-06-23 | — | — | CN | claimed |
| US-20200123673-A1 | ELECTROLYTIC TIN ALLOY PLATING SOLUTION | C. UYEMURA & CO., LTD. (JP) | 2020-04-23 | — | — | US | claimed |
| US-7544819-B2 | Process for the asymmetric epoxidation of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2009-06-09 | — | — | US | claimed |
| US-20050203303-A1 | Process for the asymmetric epoxidation of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | US | claimed |
| EP-0377357-B1 | Process for the condensation of at least one epoxide on at least one cyclic anhyhride in the presence of a titanium-based catalyst | INST FRANCAIS DU PETROLE (FR) | 1994-03-23 | — | — | EP | claimed |
| EP-0397474-A2 | Photosensitive composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-11-14 | — | — | EP | claimed |
| CN-113683557-B | Application of cyclopentadienyl iridium/rhodium dimer | 南京师范大学 | 2023-07-14 | — | — | CN | disclosed |
| CN-113559939-B | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-113713858-B | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-113683557-A | Application of cyclopentadienyl iridium/rhodium dimer | 南京师范大学 | 2021-11-23 | — | — | CN | disclosed |
| CN-108530343-B | Rhein specific group modified organic compound, aryl metal complex thereof, preparation method and application thereof | 南京师范大学 | 2021-07-27 | — | — | CN | disclosed |
| EP-2552443-B1 | IMPROVED TREATMENT OF RENAL CELL CARCINOMA | ONCORENA AB (SE) | 2021-07-14 | — | — | EP | disclosed |
| EP-0108437-B1 | PROCESS FOR THE PREPARATION OF ETHYLIDENE DIACETATE AND/OR ACETIC ACID ANHYDRIDE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-05-14 | — | — | EP | disclosed |
| US-4529824-A | Vanadium, niobium or tanatlum peroxidic complex | INSTITUT FRANCAIS DU PETROLE (FR) | 1985-07-16 | — | — | US | disclosed |
| EP-0108437-A1 | Process for the preparation of ethylidene diacetate and/or acetic acid anhydride | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-05-16 | — | — | EP | disclosed |
| EP-0002963-B1 | AQUEOUS STABILIZED FLUORESCENT LABELS, PROTEINS LABELLED THEREWITH AND METHODS OF USE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-12-21 | — | — | EP | disclosed |
| EP-0041587-A1 | Catalyst compositions, production thereof, and use in production of oxygenated organic compounds | THE STANDARD OIL COMPANY (US) | 1981-12-16 | — | — | EP | disclosed |
| EP-0002963-A1 | Aqueous stabilized fluorescent labels, proteins labelled therewith and methods of use | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1979-07-11 | — | — | EP | disclosed |
| US-3980654-A | Copper (II) complexes | EASTMAN KODAK COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203303-A1 | Process for the asymmetric epoxidation of olefins | DUOX1, DUOX2, PPOX | LMNA 4838/4885HTT 4263/4885KMT2A 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.